-
Antibody Drug Conjugates
-
Antibody Drug Conjugates
-
-
Antibody Drug Conjugates
-
Bi/Multispecifics
-
Formats & Scaffolds
-
Lead Identification & Optimization
-
Antibody Drug Conjugates
What are the key considerations for target selection to enhance ADC efficacy? What should be the pay
...
-
Bi/Multispecifics
-
-
Antibody Drug Conjugates
-
Bi/Multispecifics
-
Formats & Scaffolds
-
Lead Identification & Optimization
Drinks-Canape Reception
-
Lead Identification & Optimization
-
Lead Identification & Optimization
Does antibody pharmacology matter, and why? Is there a “right” scaffold for a specific functional go
...
-
Formats & Scaffolds
-
Lead Identification & Optimization
-
Lead Identification & Optimization
-
-
Antibody Drug Conjugates
-
Bi/Multispecifics
-
Formats & Scaffolds
-
Lead Identification & Optimization
Afternoon Refreshments
-
-
Antibody Drug Conjugates
-
Bi/Multispecifics
-
Formats & Scaffolds
-
Lead Identification & Optimization
1-2-1 Meetings / Networking Break
-
-
Antibody Drug Conjugates
-
Bi/Multispecifics
-
Formats & Scaffolds
-
Lead Identification & Optimization
1-2-1 Meetings / Networking Break
-
-
Antibody Drug Conjugates
-
Bi/Multispecifics
-
Formats & Scaffolds
-
Lead Identification & Optimization
-
-
Antibody Drug Conjugates
-
Bi/Multispecifics
-
Formats & Scaffolds
-
Lead Identification & Optimization
Networking Lunch
-
Bi/Multispecifics
-
Formats & Scaffolds
-
Lead Identification & Optimization
-
Lead Identification & Optimization
-
-
Antibody Drug Conjugates
-
Bi/Multispecifics
-
Formats & Scaffolds
-
Lead Identification & Optimization
Morning Refreshments
-
-
Antibody Drug Conjugates
-
Bi/Multispecifics
-
Formats & Scaffolds
-
Lead Identification & Optimization
1-2-1 Meetings / Networking Break
-
-
Antibody Drug Conjugates
-
Bi/Multispecifics
-
Formats & Scaffolds
-
Lead Identification & Optimization
1-2-1 Meetings / Networking Break
-
Bi/Multispecifics
-
Formats & Scaffolds
Is broad-based use of conventional IgG somewhat limited by its fundamental biophysical properties? A
...
-
Lead Identification & Optimization
-
Lead Identification & Optimization
What are the key issues faced in the in vitro degradation of antibodies, and which (bio)chemical pat
...
-
Antibody Drug Conjugates
-
-
Antibody Drug Conjugates
-
Bi/Multispecifics
-
Formats & Scaffolds
-
Lead Identification & Optimization
-
-
Antibody Drug Conjugates
-
Bi/Multispecifics
-
Formats & Scaffolds
-
Lead Identification & Optimization
Registration